Compare Pfizer with Procter & Gamble Health - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs PROCTER & GAMBLE HEALTH - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

PROCTER & GAMBLE HEALTH 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER PROCTER & GAMBLE HEALTH PFIZER/
PROCTER & GAMBLE HEALTH
 
P/E (TTM) x 42.6 17.9 237.8% View Chart
P/BV x 7.1 7.2 98.1% View Chart
Dividend Yield % 0.5 6.6 7.4%  

Financials

 PFIZER   PROCTER & GAMBLE HEALTH
EQUITY SHARE DATA
    PFIZER
Mar-19
PROCTER & GAMBLE HEALTH
Dec-18
PFIZER/
PROCTER & GAMBLE HEALTH
5-Yr Chart
Click to enlarge
High Rs3,8403,549 108.2%   
Low Rs2,0801,301 159.8%   
Sales per share (Unadj.) Rs455.0511.4 89.0%  
Earnings per share (Unadj.) Rs93.861.3 153.0%  
Cash flow per share (Unadj.) Rs109.474.0 147.8%  
Dividends per share (Unadj.) Rs22.50440.00 5.1%  
Dividend yield (eoy) %0.818.1 4.2%  
Book value per share (Unadj.) Rs658.2927.8 70.9%  
Shares outstanding (eoy) m45.7516.60 275.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.54.7 137.2%   
Avg P/E ratio x31.639.6 79.8%  
P/CF ratio (eoy) x27.132.8 82.6%  
Price / Book Value ratio x4.52.6 172.0%  
Dividend payout %24.0717.9 3.3%   
Avg Mkt Cap Rs m135,42040,257 336.4%   
No. of employees `0002.61.1 232.0%   
Total wages/salary Rs m3,2381,313 246.7%   
Avg. sales/employee Rs Th7,911.47,486.7 105.7%   
Avg. wages/employee Rs Th1,230.91,157.6 106.3%   
Avg. net profit/employee Rs Th1,630.7897.2 181.8%   
INCOME DATA
Net Sales Rs m20,8158,490 245.2%  
Other income Rs m1,674244 686.3%   
Total revenues Rs m22,4898,734 257.5%   
Gross profit Rs m5,7121,482 385.5%  
Depreciation Rs m714211 338.0%   
Interest Rs m730-   
Profit before tax Rs m6,5991,514 435.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m066 0.0%   
Tax Rs m2,309563 410.4%   
Profit after tax Rs m4,2911,017 421.7%  
Gross profit margin %27.417.5 157.2%  
Effective tax rate %35.037.1 94.2%   
Net profit margin %20.612.0 172.0%  
BALANCE SHEET DATA
Current assets Rs m27,16715,343 177.1%   
Current liabilities Rs m8,9171,960 454.9%   
Net working cap to sales %87.7157.6 55.6%  
Current ratio x3.07.8 38.9%  
Inventory Days Days6849 139.1%  
Debtors Days Days3028 105.8%  
Net fixed assets Rs m8,8621,209 732.8%   
Share capital Rs m458166 275.6%   
"Free" reserves Rs m29,65615,235 194.7%   
Net worth Rs m30,11315,401 195.5%   
Long term debt Rs m250-   
Total assets Rs m39,40017,595 223.9%  
Interest coverage x91.5NM-  
Debt to equity ratio x00-  
Sales to assets ratio x0.50.5 109.5%   
Return on assets %11.15.8 191.5%  
Return on equity %14.26.6 215.7%  
Return on capital %22.110.3 215.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4281,636 26.2%   
Fx outflow Rs m7864,368 18.0%   
Net fx Rs m-358-2,732 13.1%   
CASH FLOW
From Operations Rs m978-1,304 -75.0%  
From Investments Rs m35112,697 2.8%  
From Financial Activity Rs m-1,099-301 365.6%  
Net Cashflow Rs m23111,093 2.1%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 51.8 123.4%  
Indian inst/Mut Fund % 7.5 18.2 41.2%  
FIIs % 4.9 1.0 490.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 29.1 81.4%  
Shareholders   85,207 28,591 298.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   DIVIS LABORATORIES  WOCKHARDT  VENUS REMEDIES  FRESENIUS KABI ONCO.  FDC  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End Flat, GAIL and UPL Among Top Nifty Gainers(Closing)

Indian share markets continued their volatile trend during closing hours today and ended their day on a flat note.

Related Views on News

PFIZER Announces Quarterly Results (3QFY21); Net Profit Up 1.6% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, PFIZER has posted a net profit of Rs 1 bn (up 1.6% YoY). Sales on the other hand came in at Rs 6 bn (up 10.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (2QFY21); Net Profit Down 14.8% (Quarterly Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

For the quarter ended September 2020, PFIZER has posted a net profit of Rs 1 bn (down 14.8% YoY). Sales on the other hand came in at Rs 6 bn (up 5.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY21); Net Profit Up 57.0% (Quarterly Result Update)

Aug 31, 2020 | Updated on Aug 31, 2020

For the quarter ended June 2020, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 692 m (up 57.0% YoY). Sales on the other hand came in at Rs 6 bn (up 171.6% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PFIZER Announces Quarterly Results (1QFY21); Net Profit Up 10.3% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, PFIZER has posted a net profit of Rs 1 bn (up 10.3% YoY). Sales on the other hand came in at Rs 5 bn (down 5.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY20); Net Profit Up 5.4% (Quarterly Result Update)

Feb 19, 2020 | Updated on Feb 19, 2020

For the quarter ended December 2019, PFIZER has posted a net profit of Rs 1 bn (up 5.4% YoY). Sales on the other hand came in at Rs 5 bn (up 4.7% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Mar 8, 2021 03:32 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS